Results

Total Results: 460 records

Showing results for "vascular".

41. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
    January 01, 2007 - Peripheral vascular disease. … Only two randomized controlled trials reported information on peripheral vascular disease, making it … In the largest of the two trials (PROactive), pioglitazone had no effect on peripheral vascular disease … To improve understanding of the effects of oral diabetes medications on peripheral vascular disease, … disease medications in effects on peripheral vascular disease. 2e.

42. A Comparative Effectiveness Study of Intensive Glycemic Control vs. Less Intensive Control in Type 2 Diabetes | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/glycemic-control/abstract
    December 15, 2009 - In addition, patients with type 2 diabetes typically have other risk factors for vascular disease including

43. Treatment of Dementia Among Community-Dwelling and Institutionalized Medicare Beneficiaries (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/dementia-databases-methods_research.pdf
    May 01, 2008 - Alzheimer’s disease and related dementias (ADRD) is a global term comprising Alzheimer’s disease, vascular … Vascular dementia was defined as ICD codes 290.4x. … Less than 25% of our subjects had a claim for Alzheimer’s disease and we had a larger amount with vascular … higher number of deaths (although not statistically significant) in the treatment arm of a study in vascular … Eisai Reports Results from Latest Donepezil Study in Vascular Dementia. March 16, 2006.

44. Santa_ECCS2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/santa_eccs2012.pdf
    February 01, 2013 - . • Built ratings of common coronary or vascular disease screening tests. • Added new evidence, frequency … Slide 8: Comparison of Heart Disease Screening  Tests  (2 of 2) Image of Consumer Reports Heart/Vascular … • Society of Thoracic  Surgeons • Society of Vascular

45. Nonopioid Pharmacologic Treatments for Chronic Pain: Appendix E (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-ape_0.xlsx
    August 08, 2017 - 1.71 (1.23 to 2.37) Nonfatal stroke: 1.04 (0.73 to 1.49) Coronary death: 1.72 (0.85 to 3.49) Major vascular … 1.66) Upper GI complications: 1.81 (1.17 to 2.81) Diclofenac vs. placebo rate ratio (95% CI) Major vascular … 2.94) Upper GI complications: 1.89 (1.16 to 3.09) Ibuprofen vs. placebo rate ratio (95% CI) Major vascular … 1.09 (0.87 to 1.36) Nonfatal stroke: 0.86 (0.65 to 1.15) Coronary death: 0.71 (0.38 to 1.32) Major vascular … 2.02 (1.35 to 3.02) Nonfatal stroke: 1.19 (0.76 to 1.86) Coronary death: 2.46 (0.71 to 8.50) Major vascular

46. Chronic Venous Ulcers: A Comparative Effectiveness Review of Treatment Modalities | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/venous-ulcers-treatment/research
    January 27, 2014 - Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2014;2(2):212-25.

47. Draft Comparative Effectiveness Review Appendicies (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_appendixes.pdf
    April 01, 2005 - dis$.tw. 6 7 renal vascular dis$.tw. 156 8 (arvd or "atherosclerotic renovascular dis$").tw. 302 … Survival in renal vascular disease. … Renal vascular hypertension. Surgery vs. dilation. … Trends in reconstruction for atherosclerotic renal vascular disease. … Transluminal vascular stent for ostial atherosclerotic renal artery stenosis.

48. Cancer-Ovarian-Contraceptives Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-ovarian-contraceptives_executive.pdf
    June 01, 2013 - fDate ranges for acute vascular events associated with OC use were restricted to more recent years to … Increase in age-specific incidence of vascular events in current OC users versus noncurrent users DVT … Vascular events were increased in incidence. … The overall impact on net harms and benefits of progestin- only pills, particularly for vascular events … The noncontraceptive harms (increased risk of breast and cervical cancer and vascular events) and benefits

49. Disposition of Comments for CER 168 Infantile Hemangioma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_disposition-comments.pdf
    January 15, 2016 - a clinical diagnosis and imaging such as US and MRI sometimes cannot distinguish hemangiomas from vascular … aid when the diagnosis is in queston, rather than imaging, if the diagnosis of hemangioma versus a vascular … TEP reviewer #5 Results 15/9- IHs are vascular lesions. … They cannot outgrow their vascular supply. We have revised this statement. … Literature prior to 1982 even more likely to include other vascular anomalies under the nomenclature

50. Stroke Prevention in Atrial Fibrillation Patients: A Systematic Review Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/stroke-afib-update/research-protocol
    July 07, 2017 - are congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or TIA, vascular … ventricular ejection fraction ≤ 40%, hypertension, age ≥ 75, diabetes, stroke/TIA/thromboembolism, vascular … ventricular ejection fraction ≤ 40%, hypertension, age ≥ 75, diabetes, stroke/TIA/thromboembolism, vascular … accident”[tiab] OR “brain vascular accidents”[tiab] #4 #1 AND #2 AND #3 #5 ("diagnosis"[Mesh … accident"[tiab] OR "brain vascular accidents"[tiab])) AND ("Clinical Decision-Making"[Mesh] OR "Decision

51. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
    December 11, 2012 - mass index, diabetes, heart failure, previous stroke, renal insufficiency, type of stent, type of vascular … • Body mass index • Heart failure • Previous stroke • Renal insufficiency • Type of stent • Type of vascular … mass index, diabetes, heart failure, previous stroke, renal insufficiency, type of stent, type of vascular … mass index, diabetes, heart failure, previous stroke, renal insufficiency, type of stent, type of vascular … FDA approved TREK® PTCA Abbott Vascular FDA approved Maverick® PTCA Boston Scientific Corporation

52. Omega 3 Fatty Acids and Cardiovascular Disease - Update | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/research-protocol
    April 02, 2015 - the outcomes included and will also expand the scope to include additional CVD outcomes (peripheral vascular … including all-cause mortality, CVD mortality, non-fatal CVD events, new diagnosis of CVD, peripheral vascular … events: Fatal vascular events (e.g., due to myocardial infarction, stroke) Non-fatal vascular events … diagnosis Ventricular arrhythmia, new diagnosis Supraventricular arrhythmia, new diagnosis Major vascular … exp peripheral vascular diseases/ 63. (peripheral and vascular and disease$).mp.

53. Fatty-Acids-Cardiovascular-Disease Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_research-protocol.pdf
    April 02, 2015 - the outcomes included and will also expand the scope to include additional CVD outcomes (peripheral vascular … events: o Fatal vascular events (e.g., due to myocardial infarction, stroke) o Non-fatal vascular … Congestive heart failure, new diagnosis o Cerebrovascular disease, new diagnosis o Peripheral vascular … [mp=ti, ot, ab, nm, hw, kw, kf, px, rx, ui, an, tx, sh, ct, bt, id, cc] 62. exp peripheral vascular … (peripheral and vascular and disease$).mp.

54. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/cognitive-decline_executive.pdf
    March 01, 2017 - simultaneously, including nutrition, physical activity, cognitive training, social activity, and/or vascular … The review does include studies addressing vascular components of mixed dementia, but clear post-stroke … to the stroke prevention literature, although this study included the literature relevant to the vascular … with components addressing nutrition, physical activity, cognitive training, social activity, and/or vascular … A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring

55. Interventions To Prevent Age-Related Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer’s-Type Dementia (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline_executive.pdf
    March 01, 2017 - simultaneously, including nutrition, physical activity, cognitive training, social activity, and/or vascular … The review does include studies addressing vascular components of mixed dementia, but clear post-stroke … to the stroke prevention literature, although this study included the literature relevant to the vascular … with components addressing nutrition, physical activity, cognitive training, social activity, and/or vascular … A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring

56. Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/angina-heart-attack-treatments/research-protocol
    December 13, 2012 - unstable angina Balloons Sprinter® PTCA Medtronic FDA approved VOYAGER™ PTCA Abbott Vascular … FDA approved TREK® PTCA Abbott Vascular FDA approved Maverick® PTCA Boston Scientific … Boston Scientific Corporation FDA approved JoStent Graftmaster® Closed-cell stent Abbott Vascular … stent Boston Scientific Corporation FDA approved ACS Multi-Link® Bare-metal stent Abbott Vascular … stent Boston Scientific Corporation FDA approved XIENCE™/PROMUS™ Drug-eluting stent Abbott Vascular

57. Migraine Protocol-Appendix 20111103 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
    November 03, 2011 - CALCIUM CHANNEL BLOCKERS Nimodipine,C08CA06 C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR … Phenylalkylamine derivatives Nicardipine,C08CA04 C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR … Dihydropyridine derivatives Nifedipine,C08CA05 C08C SELECTIVE CALCIUM CHANNEL BLOCKERS WITH MAINLY VASCULAR

58. Update of Comparative Effectiveness of Lipid-Modifying Agents | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/high-cholestorol-medicines-update/research-protocol
    May 17, 2013 - Oxidized LDL is atherogenic, causing endothelial damage, alteration of vascular tone, and recruitment … harms will be evaluated in the following subgroups: patients with diabetes, patients with established vascular … Pravastatin Rosuvastatin Simvastatin Outcomes Clinical outcomes: All-cause mortality and vascular … Outcomes Clinical outcomes All-cause mortality Vascular death Fatal MI, nonfatal MI, any or unspecified … Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.

59. Hypertension-Pulmonary-Arterial Research-Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
    January 30, 2013 - obstructive pathological changes of the pulmonary microcirculation that lead to an increase in pulmonary vascular … have been found to contribute to changes in the pulmonary vasculature, causing increased pulmonary vascular … with suspected PAH and asymptomatic patients at high risk for PAH (e.g., patients with a collagen vascular … hypertension (PAH) or asymptomatic patients at high risk for PAH (e.g., patients with a collagen vascular … Patients have neither (1) a condition associated with a high risk of undiagnosed PAH (e.g., a collagen vascular

60. high-cholesterol-medicines-update-protocol-130516 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
    December 31, 2013 - Oxidized LDL is atherogenic, causing endothelial damage, alteration of vascular tone, and recruitment … harms will be evaluated in the following subgroups: patients with diabetes, patients with established vascular … Outcomes Clinical outcomes • All-cause mortality • Vascular death • Fatal MI, nonfatal MI, any or … will independently grade the strength of evidence on key outcomes—including, all-cause mortality, vascular … Rosuvastatin to  prevent vascular events in men and women with elevated C-­‐reactive protein.